Abiopharma

Axogen Announces Proposed Public Offering of Common Stock

Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast

AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions

Madrigal Pharmaceuticals Announces Grant of Inducement Award under Nasdaq Listing Rule 5635(c)(4)

Coherent Corp. Announces Timing of FY2026 Second Quarter Earnings Release

Accuray to Report Second Quarter Fiscal 2026 Financial Results on February 4, 2026

Option Care Health to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call

GRI Bio Announces Reverse Stock Split

Incoming CEO Paul Bloom and Long-Time Leader Patrick Gruber to Participate in Virtual Fireside Chat

Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2025 Financial Results